IJR News — today's news from every side

IJR News — today's news from every side

blockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

Loading

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News
Encouragement
Video
Meme Wars

Brands

Yourlist
Quizie
FaithTap
Blessed
All brands

Antibody Drug Neutralizes Virus Variants in Lab Study, COVID-19 Antibodies Detectable 12 Months After InfectionReporting — May 4, 2021The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. Experimental antibody drug…

What You Need To Know About the Coronavirus Right NowReporting — Oct 8, 2020Here’s what you need to know about the coronavirus right now: Regeneron antibodies in demand Patients are asking to join clinical trials of antibody-based COVID-19 drugs after U.S. President Donald Trump was treated…

Sen. Tim Kaine Tests Positive for Coronavirus AntibodiesReporting — May 28, 2020Sen. Tim Kaine (D-Va.) is revealing he tested positive for COVID-19 antibodies, which indicates he previously contracted the coronavirus. On Thursday, the Democratic lawmaker released a statement of confirmation on his…

COVID-19 Antibodies Present in Patients Four Months After Recovery: StudyReporting — Sep 1, 2020Antibody levels against the novel coronavirus rose and then held steady for up to four months in more than 90% of recovered COVID-19 patients in Iceland, according to a study published on Tuesday. In previous studies…

IJRAmericans Fought To Save South Korea: Are South Koreans Forgetting?James P. Pinkerton · 5 min · 1h

Next Big COVID-19 Treatment May Be Manufactured AntibodiesReporting — Aug 3, 2020As the world awaits a COVID-19 vaccine, the next big advance in battling the pandemic could come from a class of biotech therapies widely used against cancer and other disorders – antibodies designed specifically to…

YourlistRankingMost Influential Women in World HistoryFrom ancient queens who ruled empires to modern activists who changed laws, these women left indelible marks on politics, science, and culture. Vote for who you think shaped history most profoundly.1379 votes · 26 candidates

FDA Releases Changes to Policy Requiring Manufacturers to Submit Antibody Testing DataReporting — May 4, 2020The Food and Drug Administration (FDA) is cracking down on commercial manufacturers of serology tests, now requiring them to submit data to prove the accuracy of their antibody test results. On Monday, the FDA rolled…

Exclusive: US Navy Test Shows 60 Percent of Carrier Crew Have Coronavirus AntibodiesReporting — Jun 8, 2020A U.S. Navy investigation into the spread of the coronavirus aboard the Theodore Roosevelt aircraft carrier has found that about 60 percent of sailors tested had antibodies for the coronavirus, two U.S. officials told…

Los Angeles Coronavirus Infections 40 Times Greater Than Known Cases, Antibody Tests SuggestReporting — Apr 21, 2020Some 4.1% of adults tested positive for coronavirus antibodies in a study of Los Angeles County residents, health officials said on Monday, suggesting the rate of infection may be 40 times higher than the number of…

New York Test of 3,000 People Finds 14 Percent With Coronavirus AntibodiesReporting — Apr 23, 2020New York Governor Andrew Cuomo said on Thursday a screening of 3,000 people found nearly 14% tested positive for antibodies for the novel coronavirus, suggesting that 2.7 million residents across the state may have been…

On X · @bobpockrassNASCAR Reporter Shares Raw Footage of Blaney-Hocevar Bristol FightBob Pockrass posted exclusive raw video of the post-race altercation between Ryan Blaney and Carson Hocevar at Bristol. Reactions are mostly one-sided with amusement and criticism of Blaney's block and initiation, though a minority defends him or calls the response excessive. The post itself is neutral footage sharing.2,120 likes · 17m

Novel Antibody May Be Key To Better Lung Cancer TreatmentReporting — Sep 23, 2024Photo of lung scan. Novel antibody may be key to better lung cancer treatment. ANNA SHVETS VIA PEXELS. “> Lung cancer is the leading cause of cancer-related deaths, and the most common form is a non-small-cell type…

Sandoz Henlius Expand Biosimilars Alliance to Ten Assets — Aug 17, 2026Sandoz and Shanghai Henlius Biotech announced a strategic collaboration to develop and globally commercialize up to 10 monoclonal antibody and antibody-drug conjugate biosimilars outside China, with Henlius leading development and manufacturing and milestone-based total consideration potentially reaching USD 322 million. The initial deal covers cetuximab, evolocumab and belimumab biosimilars, expanding the partners’ biosimilars pipeline amid a broader push to capture a growing segment of the loss-of-exclusivity market.

YourlistVS BattleSoccer vs American FootballThe world's game versus America's obsession — simplicity against spectacle.Soccer vs American Football · 146 votes — pick a side

‘No Evidence’ That Recovered COVID-19 Patients Cannot Be Reinfected: WHOReporting — Apr 26, 2020– The World Health Organization (WHO) said on Saturday that there was currently “no evidence” that people who have recovered from COVID-19 and have antibodies are protected from a second coronavirus infection. In a…

GSK pays Hutchmed $110M upfront in deal worth up to $1.3B — Sep 3, 2026GSK agreed to license Hutchmed’s HMPL-A830, a KRAS-EGFR antibody-drug conjugate, for up to $1.295 billion including $110 million upfront, with global rights outside Mainland China, Hong Kong, Macau and Taiwan while Hutchmed retains development and commercialization duties in those regions. The collaboration targets initial trials in colorectal, pancreatic, and lung cancers, leveraging a dual KRAS-EGFR mechanism to improve efficacy and tolerability.

Jared Kim Dual-targeting KRAS-EGFR is an interesting bet, hope it actually improves tolerability and not just adds complexity.

Roche seals $1.53B Simcere trispecific deal — Sep 1, 2026Roche agreed to pay $75 million upfront to acquire exclusive global rights to SIM0660, a preclinical trispecific antibody from Simcere Zaiming that targets CD79a, CD19 and CD3, with total potential payments up to $1.53 billion and tiered royalties up to double digits. The therapy is designed to trigger T-cell–mediated killing across B-cell–mediated diseases, including autoimmune conditions, highlighting a growing collaboration between Roche and a Chinese biotech.

Maya Lindstrom Chinese biotech deals with big pharma keep growing, Simcere Zaiming landing this shows their pipeline is getting real attention.

DDaily Caller News FoundationAmericans Fought To Save South Korea: Are South Koreans Forgetting?On September 16, 1950, this in The New York Times: "Dad’s Letter Tells Two Little Girls Why He Went to Korea — And Died." 1h

Trump Falsely Claims ‘We Have a Cure’ for COVID-19Reporting — Oct 9, 2020President Donald Trump is certain the Regeneron antibody he received after being diagnosed with COVID-19 is a cure rather than a therapeutic, but leading health experts do not seem to agree. “We’re rounding the turn on…

QuizieQuizCan you still pass 6th grade?Fifteen questions straight from middle school — math, science, English, civics. The AI decides if you graduate. Again.4 min · today's quiz

My COVID-19 Story: I Feared the Virus, but Welcomed the AntibodiesReporting — May 26, 2020Shushannah Walshe is IJR’s editor at large. This is her personal essay on her own COVID-19 experience. It was mid-March when I woke up at 2:30 a.m., feeling feverish. It was at the very beginning of the global pandemic…

George Stephanopoulos Shares That He Is Donating His Plasma After Recovering From the CoronavirusReporting — Apr 21, 2020ABC News’ George Stephanopoulos says he has fully recovered from the coronavirus and is donating his plasma to a COVID-19 study. On ABC’s “Good Morning America” on Tuesday, Stephanopoulos said he took an antibody test…

Lilly Plans $2.88B Merida Autoimmune AcquisitionBusiness — Sep 3, 2026Eli Lilly is rapidly expanding beyond its obesity-and-diabetes blockbuster lineup, striking two multi-deal paths: a $2.875 billion-plus acquisition of Merida Biosciences to broaden its autoimmune and antibody-directed therapies, and a $3.83 billion spree to acquire three biotech firms—Curevo, LimmaTech Biologics, and Vaccine Company—to build a broader vaccine and infectious-disease pipeline. The moves underscore a strategy to diversify growth into immunology, infectious diseases, and autoantibody therapies while managing revenue risk from reliance on a small number of weight‑loss drugs.

After ’21 Days of Hell’ New York Governor Expands Coronavirus TestingReporting — Apr 26, 2020– New York will on Saturday begin conducting antibody tests for workers at four hospitals hit hardest by the coronavirus pandemic and will allow local pharmacies to begin collecting samples for diagnostic tests…

IJRSouth Dakota Secretary Of State Bucks Party, Endorses Democrat To Be SuccessorSpencer Lombardo · 3 min · 2h

Regeneron’s Drug Becomes First FDA-Approved Ebola Virus TreatmentReporting — Oct 14, 2020The U.S. Food and Drug Administration on Wednesday approved Regeneron Pharmaceuticals’ triple antibody cocktail as the first Ebola virus treatment, lending validation to similar drugs being developed for COVID-19…

Conservative Radio Host Says He Tested Positive for COVID After Trying to Contract the VirusReporting — Oct 19, 2021Conservative radio host Dennis Prager says he intentionally contracted COVID-19 and received monoclonal antibodies to “achieve natural immunity” instead of getting vaccinated against the virus. On Monday, Prager said, “…

Tents and Immunity Testing: US Colleges Weigh Return to Campus LifeReporting — May 5, 2020Classes in tents. Roommates assigned based on coronavirus antibody tests. Residences set aside for quarantined students. U.S. college life could look dramatically different when classes resume in the fall. Colleges…

Pfizer COVID-19 Vaccine Safe, Effective on Adolescents in Trial, Companies SayReporting — Mar 31, 2021Pfizer Inc and BioNTech SE said on Wednesday their COVID-19 vaccine was safe and effective and produced robust antibody responses in 12- to 15-year olds, paving the way for them to seek U.S. emergency use authorization…

Genentech-DualityBio Global ADC Deal Over $1BBusiness — Aug 28, 2026DualityBio and Genentech (Roche) have launched a global collaboration to develop next-generation antibody-drug conjugates using the DUPAC payload platform, featuring a $45 million upfront and potential milestones exceeding $1 billion, with DualityBio leading early discovery and Genentech obtaining exclusive worldwide rights after Phase 1a. The program targets tumors resistant to current topoisomerase-inhibitor–based ADCs, backed by preclinical data and potential expansion into China via the Dupac platform.

On X · @barstoolsportsOle Miss Defeats LSU in Lane Kiffin’s Return to OxfordBarstool Sports posted a hype video celebrating Ole Miss’s victory over LSU, framing it as “sweet sweet revenge” against former Rebels coach Lane Kiffin. The post highlights key plays and the emotional narrative of Kiffin’s return to Oxford. It is trending due to the high-stakes SEC rivalry and strong engagement from college football fans.2,213 likes · 18m